Tauopathies were long viewed as diseases of the mature brain: tau accumulates, neurons die, dementia sets in. But a growing body of data suggests that pathogenic tau can also do damage at early stages, when the brain is still being built. Alongside this paper, our archive holds studies on brain shrinkage in Alzheimer's disease, on genetic maps of cancer, and on how neural networks read medical histories. All of them are hunting for early disease signals, yet almost no one looks at the stage when neural circuits are forming. This article fills that gap: it shows that mutant tau P301L breaks the architecture of the Drosophila brain even before any signs of degeneration appear.
The authors created transgenic flies whose neurons express either wild-type human tau or the P301L mutant linked to hereditary frontotemporal dementia. Both variants were tagged with the green fluorescent protein eGFP so that their localization could be tracked in the living brain. The flies were kept on standard medium, and behavioral tests used an automated activity monitoring system that records movement by infrared beam crossings. Sleep was defined as a continuous period of immobility lasting at least five minutes. Motor impairment was assessed with a negative geotaxis test: flies were placed in a vial and the number of individuals that climbed 10 centimeters up within 30 seconds was counted. Brain structure was studied on stained sections, and pathological tau forms were isolated using the detergent sarkosyl, which does not dissolve aggregated protein.
Expression of mutant tau P301L in Drosophila neurons led to hyperphosphorylation of the protein, a key hallmark of tauopathies. The flies' lifespan shrank: median survival dropped by 15% compared with controls. Sleep was disrupted: total sleep time fell by roughly half, while daytime and nighttime activity more than doubled. Motor impairments developed with age: by day 30 of life, the flies' ability to climb up had declined by 70%. Histological analysis revealed progressive neurodegeneration: by day 60, almost all P301L flies had vacuoles in the brain, cavities where dead neurons had been. But the most unexpected finding was disrupted development of the mushroom bodies, the structures responsible for learning and memory. In flies expressing P301L from the moment of hatching, Kenyon cell axons failed to form normal lobes, and this defect did not arise if expression was switched on only in adulthood. So mutant tau strikes the developing brain separately from its role in degeneration.
The work shows that tauopathies have two phases: an early one tied to disrupted formation of neural circuits, and a late one tied to degeneration. Neighboring studies in our archive focus on adult pathologies: brain shrinkage, cancer genetics, analysis of medical records. Here, for the first time at the level of the whole organism, it is demonstrated that mutant tau P301L can break the brain's architecture during development. This changes the picture of when the disease begins and opens a window for intervention long before symptoms appear.
The Drosophila model makes it possible to test drugs and modifier genes quickly. In the future, researchers can work out in detail which signaling pathways the 5-HT7 receptor activates in neurons and find more specific targets. It would also be promising to investigate whether mutant tau affects brain development in mammals, and whether early defects can be reversed if treatment starts in time.
The results matter for developmental neuroscience, tauopathy research, and drug development for dementia. They also provide a tool for screening compounds capable of modifying tau pathology.
Check whether the protective effect of 5-HT7 blockade holds in mice with tauopathy. Determine which kinases phosphorylate tau in the Drosophila model and how this relates to impaired axon growth.
In the tauopathy field, one question remains unresolved: which form of tau is toxic, soluble oligomers, fibrils, or intermediate aggregates. This work shows that pathological tau accumulation can be measured and modified, but it does not pin down the exact toxic structure. It also remains a mystery why some neurons are more vulnerable than others, and how early developmental disruptions connect to late degeneration.
The mushroom bodies of Drosophila are named for their resemblance to a mushroom cap. They consist of just a few thousand neurons, yet they govern complex behavior, including learning and memory. In flies with mutant tau, these structures can be missing entirely, even though the neurons themselves stay alive.
The idea that neurodegeneration begins long before symptoms echoes Daniel Keyes's novel Flowers for Algernon, where the protagonist's intellectual decline is portrayed as the gradual unraveling of neural connections that were once formed.
Not published on arXiv. Here are its page, the PDF and the formalization: you can check it yourself, not only read our account.